Compare IMNM & COCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNM | COCO |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 2020 | 2021 |
| Metric | IMNM | COCO |
|---|---|---|
| Price | $22.03 | $76.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $32.80 | ★ $57.75 |
| AVG Volume (30 Days) | 915.1K | ★ 1.6M |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.40 | 26.60 |
| EPS | N/A | ★ 0.50 |
| Revenue | ★ $6,941,000.00 | N/A |
| Revenue This Year | N/A | $16.12 |
| Revenue Next Year | $1,127.34 | $11.40 |
| P/E Ratio | ★ N/A | $151.99 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.96 | $31.82 |
| 52 Week High | $27.65 | $79.99 |
| Indicator | IMNM | COCO |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 68.77 |
| Support Level | $19.23 | $50.99 |
| Resistance Level | $23.24 | $79.99 |
| Average True Range (ATR) | 1.27 | 2.73 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 55.07 | 76.77 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.